NCT04962698

Brief Summary

This project will develop and test a new paradigm of motor imagery for facilitating neuromotor excitability and performance of distal muscles in the upper limb by adopting a robotic prosthesis and integrating proven procedures for neuromotor facilitation. The scientific purpose of the study is to understand the effect of controlling a detached robotic prosthesis with proximal muscle activation on brain excitability of the resting arm muscles as well as reaction time. The efficacy of this task will be understood by comparing with other task conditions (motor imagery only, 2D visual feedback on a monitor, etc.) that do not involve the robotic prosthesis. The test of the developed system will be performed in healthy able-bodied adults. The feasibility of the system will be examined in post-stroke adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 15, 2021

Completed
10 months until next milestone

Study Start

First participant enrolled

May 11, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2023

Completed
5 months until next milestone

Results Posted

Study results publicly available

October 19, 2023

Completed
Last Updated

October 19, 2023

Status Verified

August 1, 2023

Enrollment Period

1 year

First QC Date

July 2, 2021

Results QC Date

August 25, 2023

Last Update Submit

September 27, 2023

Conditions

Keywords

HandImageryRobot

Outcome Measures

Primary Outcomes (5)

  • MEP Amplitude

    Peak-to-peak amplitude of motor evoked potential (MEP) of the hand muscle

    1 day

  • Reaction Time

    Reaction time of the index finger in response to an auditory cue (reaction time test)

    1 day

  • Peak EMG

    Peak EMG amplitude of the hand muscle during the reaction time test was determined in each intervention. After identifying the maximal peak EMG value among the interventions, peak EMG value in each task was normalized to that maximal peak EMG, expressed as the ratio.

    1 day

  • Maximal Rate of Force Development

    Maximal rate of force development during a reaction time test

    1 day

  • Peak Force

    Peak force of the index finger during a reaction time test

    1 day

Study Arms (2)

Healthy participants

EXPERIMENTAL

All participants will receive seven types of interventions in random order. The types of interventions are the same across subjects.

Behavioral: Visual motor imagery (MI)Behavioral: Kinesthetic MIBehavioral: Robotic-Hand Interaction with MIBehavioral: Robotic-Hand Interaction without MIBehavioral: Virtual-Hand InteractionBehavioral: Robotic Action ObservationBehavioral: Rest

Post-Stroke participants

EXPERIMENTAL

All participants will receive three types of interventions in random order. The types of interventions are the same across subjects.

Behavioral: Visual motor imagery (MI)Behavioral: Robotic-Hand Interaction with MIBehavioral: Rest

Interventions

Subjects will relax their muscles and perform conventional visual motor imagery (MI). With the guidance of audio instruction, the subjects will imagine the grasp and release motions with the right arm for 2 s in each motion in their mind. There will be no proximal muscle contraction.

Healthy participantsPost-Stroke participants
Kinesthetic MIBEHAVIORAL

The same MI procedure as Visual MI will be performed, except that the subjects will focus on the kinesthetic sensation that they would feel with the imagined motions.

Healthy participants

Subjects will perform robotically augmented mental practice for grasp and release motions with the activation control of the proximal muscles. During this task, subjects will also imagine the kinesthetic sensation that they would feel with the corresponding motions with the right arm.

Healthy participantsPost-Stroke participants

Subjects will perform the Robot-Hand Interaction without MI.

Healthy participants

Subjects will interact with visual feedback of virtual robot actions on a monitor.

Healthy participants

Subjects will relax their muscles and focus on observing the computer-controlled grasp and release actions of the robotic hand.

Healthy participants
RestBEHAVIORAL

Subjects will rest without a task.

Healthy participantsPost-Stroke participants

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old, men and women
  • years old
  • Right-handed
  • Longer than 6 months post-stroke
  • Persistent hemiparesis on the right upper extremity (UE)
  • Residual UE voluntary movement as indicated by a score of 1-3 on the motor arm item of the NIH Stroke Scale (NIHSS) and a score of 19-55 on the UE portions of the Fugl Meyer Assessment (UE-FMA)
  • Preserved cognitive function
  • Ability to follow and read simple instructions as indicated by a score of 1 or above on item #9 on the best language items of the NIHSS

You may not qualify if:

  • Had an adverse reaction to TMS. Had epilepsy or seizure.
  • Have any implanted devices such as a neurostimulator or cochlear implant.
  • Had a stroke or lesion (including tumor) in your brain\*. Had a head injury or brain surgery\*.
  • Suffer from frequent or severe headaches.
  • Had a fainting spell or syncope.
  • Have any metal in the head such as shrapnel, surgical clips, or fragments from welding or metalwork.
  • Have any implanted device such as cardiac pacemakers, medical pumps, or intra-cardiac lines.
  • Had any brain-related conditions\*.
  • Had any illness that caused brain injury\* (i.e. meningitis, aneurysm, brain tumor).
  • Had any head trauma that was associated with a loss of consciousness or diagnosed as a concussion.
  • Being treated for any psychiatric condition (i.e. depression, anxiety, PTSD, schizophrenia).
  • Had more than 2 cups of coffee/caffeinated beverages in the last 12 hours.
  • Had more than 2 alcoholic beverages in the last 12 hours.
  • Had less than 6 hours of sleep in the last 24 hours.
  • Suspected of pregnancy.
  • +17 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Neuromuscular Physiology Lab

Atlanta, Georgia, 30332, United States

Location

MeSH Terms

Conditions

Stroke

Interventions

RE1-silencing transcription factor

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Prof. Minoru Shinohara
Organization
Georgia Institute of Technology

Study Officials

  • Minoru Shinohara, Ph.D.

    Georgia Institute of Technology

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Participants in a single group will receive various types of interventions in random order. The types of interventions are the same across subjects.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2021

First Posted

July 15, 2021

Study Start

May 11, 2022

Primary Completion

May 16, 2023

Study Completion

May 16, 2023

Last Updated

October 19, 2023

Results First Posted

October 19, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations